IRIC - Institute for Research in Immunology and Cancer

The Pillars of IRIC: meet Sandra Weber

In 2023, IRIC celebrates its 20th anniversary. Among the initiatives put in place to celebrate this anniversary, the series of portraits entitled “The Pillars of IRIC” will highlight the people who have contributed since the very beginning, sometimes in the shadows, to make IRIC what it has become.

Today, meet Sandra Weber, Research Advisor in Marc Therrien’s laboratory at IRIC.

The Pillars of IRIC: meet Mélanie Fréchette

In 2023, IRIC celebrates its 20th anniversary. Among the initiatives put in place to celebrate this anniversary, the series of portraits entitled “The Pillars of IRIC” will highlight the people who have contributed since the very beginning, sometimes in the shadows, to make IRIC what it has become.

Today, meet Mélanie Fréchette, Animal Health Technician in Guy Sauvageau’s laboratory.

Success for the IRIC 2023 symposium!

On October 19 and 20, over 250 guests gathered for IRIC’s international scientific symposium. The event was also an opportunity for everyone to officially mark IRIC’s 20th anniversary at Université de Montréal.

A CRS grant to validate therapeutic targets in liver cancer

The team led by Sylvain Meloche, Director of IRIC’s Signaling and Cell Growth Research Unit, has been awarded a two-year grant of $125,000 for the project “Advanced preclinical validation of SRC-family kinases as therapeutic targets in liver cancer”. This grant is funded in partnership with the Canadian Liver Foundation.

Lucyle Depoërs, doctoral student and science communicator, presents the magazine L’ÉclairSci

IRIC is proud to support the creation of the new magazine l‘ÉclairSci. Initiated by doctoral student Lucyle Depoërs, from Claude Perreault’s laboratory, the project will present scientific studies carried out by IRIC teams in the form of popularized infographics. In a digital form, l‘ÉclairSci aims to share the latest advances in cancer research with the general public.

The Pillars of IRIC: meet Jinny Émond

­­­­In 2023, IRIC celebrates its 20th anniversary. Among the initiatives put in place to celebrate this anniversary, the series of portraits entitled “The Pillars of IRIC” will highlight the people who have contributed since the very beginning, sometimes in the shadows, to make IRIC what it has become.

Today, meet Jinny Émond, Animal Care Worker In vivo Biology Core Facility.

A new platform to predict the safety of drug compounds

With their ability to activate multiple signaling pathways at different locations in the cell, G protein-coupled receptors (GPCRs) are prime targets for drug development. Shane C. Wright, from the Karolinska Institute in Sweden, has managed to harness new technology developed during his time as a postdoctoral fellow in the laboratory of Michel Bouvier, CEO of IRIC and Director of its Molecular Pharmacology Research Unit, that can potentially be used to predict adverse effects of new treatments prior to their use in the clinic. The study, a joint effort by the Swedish and Montreal teams, has been published in the journal Nature Communications.